Evogene's stock surged on news of ICL's acquisition of Lavie Bio's operations, strengthening ICL's position in ag-biologicals ...

TEL AVIV, Israel, April 23, 2025--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to ...

ICL currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. DuPont de Nemours, Inc. DD logged adjusted earnings of $1.18 per ...

Key assets to be transferred to ICL include Lavie Bio's core team, the BDD technology platform, the company's microbial bank and data assets, the majority of the company's development programs ...

The top executives from ICL Group Ltd., or ICL (NYSE: ICL), which has its North American headquarters in Creve Coeur, flew in from Tel Aviv to escort a select group of customers on a tour of the ...

ICL Group Ltd’s ICL shares have gained 23.9% ... Sylvamo Corporation SLVM and ATI Inc. ATI. Carpenter Technology currently sports a Zacks Rank #1 (Strong Buy). CRS beat the Zacks Consensus ...

ICL Group Ltd. engages in the manufacture of mineral-based products for the agriculture, food, and engineered materials markets. Its products include potash and phosphate fertilizers, specialty ...

In a report released today, Benjamin Theurer from Barclays maintained a Hold rating on Icl (ICL – Research Report), with a price target of $7.00. The company’s shares closed yesterday at $6.36.

REHOVOT, Israel, April 21, 2025 /PRNewswire/ --Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) a leading computational biology company focused on revolutionizing life-science-based product discovery and ...

This transaction follows strategic investment by ICL Planet and more than two years of close collaboration between ICL and Lavie Bio, focused on developing innovative bio-stimulant solutions for ...